Rubi, a startup aiming to revolutionize manufacturing by turning carbon emissions into essential materials, has secured $7.5 million in fresh funding. This marks a major step towards large-scale commercialization as demand surges.
The round was co-led by AP Ventures and FH One Investments, with backing from Talis Capital, CMPC Ventures, H&M Group, Understorey Ventures, and a group of angel investors. The capital will be used to scale Rubi’s production system to industrial demonstration level, expand its product pipeline, and further develop its engineered enzymes to boost efficiency while cutting costs.
The announcement caps a breakout year for the company, which has rapidly moved from early pilots to real commercial traction. Rubi has signed multi-year offtake term sheets worth more than $60 million with major fashion brands and manufacturers, while doubling its partnerships from seven to 15—including collaborations with Walmart and Reformation.
The company has also completed successful fiber performance tests and expanded into new pilot programs in the consumer packaged goods and aerospace sectors.
Crucially, Rubi is now transitioning from pilot projects into larger-scale production testing—an inflection point that signals its technology is ready for broader industrial adoption.
"We started Rubi with the vision that cell-free, multi-enzyme pathways would unlock efficient, scalable, high-performance manufacturing for critical materials from CO2," said Neeka Mashouf, Co-Founder and CEO of Rubi.
"We've now demonstrated this technology scales effectively and meets or exceeds customer product standards, driving an inflection point of commercialization. The fresh funding will accelerate our scaling and growth to meet strong global demand for modular and affordable manufacturing of essential materials from waste carbon across textile, CPG, aerospace, and chemicals verticals."
